Apmonia Therapeutics laureate from EIC accelerator program
stephanie.dhont2024-07-17T11:54:52+02:00Apmonia Therapeutics will receive €2.5 million in funding and €7 [...]
July 2024
May 2024
HEPHAISTOS secures €10.3 M to reach the clinical stage
stephanie.dhont2024-05-22T14:40:24+02:00HEPHAISTOS-Pharma welcomes Elaia to complete its Seed Round, securing a [...]
December 2023
PDC*line Pharma completes enrolment of four cohorts of patients in PDC-LUNG-101 phase I/II clinical trial
stephanie.dhont2023-12-06T15:54:43+01:00PDC*line Pharma, a clinical stage biotech company developing a new [...]
June 2023
Newsletter MATWIN June 2023
stephanie.dhont2023-06-12T14:33:52+02:00Download here the latest MATWIN newsletter :
MATWIN – PSCC partnership – Interview Benjamin Garel
stephanie.dhont2023-06-08T13:08:56+02:00Interview of Benjamin GAREL, General Manager of Paris Saclay Cancer [...]
MATWIN is hiring a R&D Project Manager (Oncology)
stephanie.dhont2023-06-08T13:10:05+02:00You dream of taking part in an exciting and meaningful [...]
MATWIN BOARD MEETING 2023
stephanie.dhont2023-06-02T15:54:04+02:00A unique committee in Europe, the MATWIN Board is made [...]
May 2023
PR: MATWIN highlights about thirty innovative projects to tackle cancer
stephanie.dhont2023-05-16T08:51:06+02:00Download the press release:
PR: MATWIN and the Paris Saclay Cancer Cluster join their forces to accelerate innovation in the fight against cancer
stephanie.dhont2023-05-09T10:57:42+02:00MATWIN and the Paris Saclay Cancer Cluster join their forces [...]
February 2023
BIPER THERAPEUTICS RAISES €1.25 MILLION
stephanie.dhont2023-02-14T12:07:14+01:00BiPer Therapeutics, awarded during OUI (Oncology Upward Investment) 2021 edition [...]